Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,722,966
-$96,450 QoQ
Shares Held
4,758
-8.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,362
of 3,140 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairfield Financial Advisors, LTD holds $15,764,978 across 4 Drug Manufacturers - General names. AMGN ranks #2 (10.9% of the industry book) .
All Filings in AMGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,722,966 | 4,758 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,819,416 | 5,171 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,746,198 | 5,335 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,655,103 | 5,865 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,079,835 | 7,449 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,332,886 | 7,488 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,099,715 | 8,056 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,669,187 | 8,284 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,528,032 | 8,091 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $2,100,817 | 7,294 | Shares | Sole | 2024-11-04 | |
| 2023-09-30 | $1,878,901 | 6,991 | Shares | Sole | 2024-11-04 | |
| 2023-06-30 | $1,409,160 | 6,347 | Shares | Sole | 2024-11-04 | |
| 2023-03-31 | $1,172,245 | 4,849 | Shares | Sole | 2024-11-04 | |
| 2022-12-31 | $1,110,967 | 4,230 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $865,986 | 3,842 | Shares | Sole | 2024-10-07 | |
| 2022-06-30 | $820,650 | 3,373 | Shares | Sole | 2024-10-07 | |
| 2022-03-31 | $842,984 | 3,486 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||